These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11198639)

  • 1. Lymphatic filariasis in Ghana: from research to control.
    Gyapong JO
    Trans R Soc Trop Med Hyg; 2000; 94(6):599-601. PubMed ID: 11198639
    [No Abstract]   [Full Text] [Related]  

  • 2. Call to consolidate achievements for onchocerciasis and lymphatic filariasis control.
    Hoerauf A; Walter RD; Remme H; Lazdins J; Fleischer B
    Trends Parasitol; 2001 Dec; 17(12):566-7. PubMed ID: 11756020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intervention research on onchocerciasis and lymphatic filariasis.
    Wkly Epidemiol Rec; 2000 Jul; 75(30):246-8. PubMed ID: 10946596
    [No Abstract]   [Full Text] [Related]  

  • 4. Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges.
    Tediosi F; Steinmann P; de Savigny D; Tanner M
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2446. PubMed ID: 24244762
    [No Abstract]   [Full Text] [Related]  

  • 5. Eliminating lymphatic filariasis, onchocerciasis, and schistosomiasis from the americas: breaking a historical legacy of slavery.
    Lammie PJ; Lindo JF; Secor WE; Vasquez J; Ault SK; Eberhard ML
    PLoS Negl Trop Dis; 2007 Nov; 1(2):e71. PubMed ID: 18060085
    [No Abstract]   [Full Text] [Related]  

  • 6. Nigeria's war on terror: fighting dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis at the grassroots.
    Njepuome NA; Hopkins DR; Richards FO; Anagbogu IN; Pearce PO; Jibril MM; Okoronkwo C; Sofola OT; Withers PC; Ruiz-Tiben E; Miri ES; Eigege A; Emukah EC; Nwobi BC; Jiya JY
    Am J Trop Med Hyg; 2009 May; 80(5):691-8. PubMed ID: 19407107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic filariasis: setting the scene for elimination.
    Molyneux DH; Neira M; Liese B; Heymann D
    Trans R Soc Trop Med Hyg; 2000; 94(6):589-91. PubMed ID: 11198635
    [No Abstract]   [Full Text] [Related]  

  • 8. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time.
    Evans DS; Unnasch TR; Richards FO
    Lancet; 2015 May; 385(9983):2151-2. PubMed ID: 26068266
    [No Abstract]   [Full Text] [Related]  

  • 9. The Current Status of Molecular Xenomonitoring for Lymphatic Filariasis and Onchocerciasis.
    Pilotte N; Unnasch TR; Williams SA
    Trends Parasitol; 2017 Oct; 33(10):788-798. PubMed ID: 28756911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of the eradicability of filarial infections: a conceptual approach.
    Duerr HP; Dietz K; Eichner M
    Trends Parasitol; 2005 Feb; 21(2):88-96. PubMed ID: 15664532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate parasitic diseases.
    Behbehani K
    Bull World Health Organ; 1998; 76 Suppl 2(Suppl 2):64-7. PubMed ID: 10063677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investing in justice: ethics, evidence, and the eradication investment cases for lymphatic filariasis and onchocerciasis.
    Bailey TC; Merritt MW; Tediosi F
    Am J Public Health; 2015 Apr; 105(4):629-36. PubMed ID: 25713967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction: Opportunities to work together: intestinal helminth control and programmes to eliminate lymphatic filariasis.
    Cline BL; Savioli L; Neira M
    Parasitology; 2000; 121 Suppl():S3-4. PubMed ID: 11386689
    [No Abstract]   [Full Text] [Related]  

  • 14. Towards a strategic plan for research to support the global program to eliminate lymphatic filariasis. Summary of Immediate needs and opportunities for research on lymphatic filariasis. Philadelphia, Pennsylvania, USA, December 9-10, 2003.
    Am J Trop Med Hyg; 2004 Nov; 71(5 Suppl):iii, 1-46. PubMed ID: 15574967
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of NGDOs in disease elimination programmes: the lessons from onchocerciasis control.
    Cross C
    Trans R Soc Trop Med Hyg; 2000; 94(6):601-2. PubMed ID: 11198640
    [No Abstract]   [Full Text] [Related]  

  • 16. New insights into the biology of filarial infections.
    Specht S; Wanji S
    J Helminthol; 2009 Jun; 83(2):199-202. PubMed ID: 19379544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global programme to eliminate lymphatic filariasis: progress report, 2016.
    Wkly Epidemiol Rec; 2017 Oct; 92(40):594-607. PubMed ID: 28984121
    [No Abstract]   [Full Text] [Related]  

  • 18. Filariasis.
    Routh HB; Bhowmik KR
    Dermatol Clin; 1994 Oct; 12(4):719-27. PubMed ID: 7805301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review.
    Keating J; Yukich JO; Mollenkopf S; Tediosi F
    Acta Trop; 2014 Jul; 135():86-95. PubMed ID: 24699086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
    Fischer PU; King CL; Jacobson JA; Weil GJ
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.